These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3890276)
21. Combined cyclophosphamide chemotherapy and maltose tetrapalmitate immunotherapy in the treatment of transplanted bladder and prostate carcinoma of the rat. Ibrahiem EH; Nigam VN; Brailovsky CA; Backman BD; Elhilali MM Cancer Res; 1984 Feb; 44(2):536-42. PubMed ID: 6537897 [TBL] [Abstract][Full Text] [Related]
22. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383 [TBL] [Abstract][Full Text] [Related]
23. [Radiotherapy of lung cancer]. Samija M; Juretić A; Zivković M; Deponte V; Herceg T; Sobat H; Solarić M; Purisić A; Matković I; Tomek R Lijec Vjesn; 1999; 121(11-12):358-66. PubMed ID: 10836086 [TBL] [Abstract][Full Text] [Related]
24. A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. "Petites Cellules" Group. Lebeau B; Urban T; Bréchot JM; Paillotin D; Vincent J; Leclerc P; Meekel P; L'Her P; Lebas FX; Chastang C Cancer; 1999 Oct; 86(8):1480-7. PubMed ID: 10526276 [TBL] [Abstract][Full Text] [Related]
25. [Problems of combined chemo- and radiotherapy]. Sheval'e A Med Radiol (Mosk); 1965 Aug; 10(8):24-32. PubMed ID: 5870528 [No Abstract] [Full Text] [Related]
26. Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens. Sládek NE; Kollander R; Sreerama L; Kiang DT Cancer Chemother Pharmacol; 2002 Apr; 49(4):309-21. PubMed ID: 11914911 [TBL] [Abstract][Full Text] [Related]
27. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III]. Bustová I Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435 [TBL] [Abstract][Full Text] [Related]
28. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors. Nitta K; Tanaka T; Takeuchi M Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657 [TBL] [Abstract][Full Text] [Related]
29. [Immunological analysis of chemotherapeutic effects for the effective immunochemotherapy against cancer]. Yamada Y Hokkaido Igaku Zasshi; 1984 Nov; 59(6):721-7. PubMed ID: 6397415 [TBL] [Abstract][Full Text] [Related]
30. [Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)]. Bacci G; Ferrari S; Rosito P; Barbieri E; Mercuri M; Brach del Prever A; Iantorno D; Forni C; Campanacci M Minerva Pediatr; 1995 Nov; 47(11):457-69. PubMed ID: 8684341 [TBL] [Abstract][Full Text] [Related]
31. [Evaluation of efficacy of treatment for 30 children with neuroblastoma]. Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065 [TBL] [Abstract][Full Text] [Related]
32. Chemoradiotherapy: emerging treatment improvement strategies. Milas L; Mason KA; Liao Z; Ang KK Head Neck; 2003 Feb; 25(2):152-67. PubMed ID: 12509799 [TBL] [Abstract][Full Text] [Related]
33. Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy. Munoz R; Man S; Shaked Y; Lee CR; Wong J; Francia G; Kerbel RS Cancer Res; 2006 Apr; 66(7):3386-91. PubMed ID: 16585158 [TBL] [Abstract][Full Text] [Related]
34. Bio-immunotherapy for cancer in experimental studies and clinical application: current status and future challenges. Shen RN; Lu L; Kaiser HE; Broxmeyer HE In Vivo; 1994; 8(5):643-52. PubMed ID: 7727711 [TBL] [Abstract][Full Text] [Related]
35. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide. Ning S; Knox SJ Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556 [TBL] [Abstract][Full Text] [Related]
36. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells. Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733 [TBL] [Abstract][Full Text] [Related]
37. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model. Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173 [TBL] [Abstract][Full Text] [Related]
38. Problem of sequence and fractionation in the clinical application of combined heat and radiation. Arcangeli G; Nervi C; Cividalli A; Lovisolo GA Cancer Res; 1984 Oct; 44(10 Suppl):4857s-4863s. PubMed ID: 6380717 [TBL] [Abstract][Full Text] [Related]
39. Combined radiotherapy and chemotherapy for treatment of unresectable and or metastatic cancer. Glenn EH; Cole D; Wunderlich HO Int J Clin Pharmacol; 1974 Jan; 9(1):37-40. PubMed ID: 4593128 [No Abstract] [Full Text] [Related]
40. [Studies on the combined treatment with cyclophosphamide and virus in mice transplanted with S180 ascitic tumor cells]. Jia FL; Huang CH; Cai J; Li Y Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Oct; 7(5):376-9. PubMed ID: 2938760 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]